•    Empirical fluoroquinolones had equal effectiveness to broad-spectrum beta-lactams in Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors.
•    Hospital length of stay was shorter in the fluoroquinolone than broad-spectrum beta-lactam group likely due to earlier transition from intravenous to oral therapy.


Maksym Kozlenko [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], from Wikimedia Commons

Read more…

The post Empirical Fluoroquinolones versus Broad-Spectrum Beta-Lactams for Gram-Negative Bloodstream Infections in the Absence of Antimicrobial Resistance Risk Factors appeared first on Healthier Environment Living Program.